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Letters to the Editorbody radiation. We are grateful for
the opportunity to discuss these
important issues with you and
look forward to further advances in
the postoperative surveillance and
treatment of lung cancer.
Andrew Pierre, MD, MSc
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We read with interest the article by
Kennedy and colleagues,1 ‘‘Does the
Society of Thoracic Surgeons Risk
Score Accurately Predict Operative
Mortality for Patients With Pulmo-
nary Hypertension?’’ We concur with
Kennedy and colleagues1 that the
current Society of Thoracic Surgeons
system2 poorly models patients with
elevated pulmonary arterial pressure
(PAP) or associated right heart
dysfunction. In our experience and
that of others, patients undergoing car-
diac surgery with PAP hypertension
have worse outcomes than patients
without PAP elevation. An important
question is why is PAP hypertension
an important prognostic marker? To
complement the work by Kennedy
Kennedy and colleagues,1 we would
like to emphasize that although1716 The Journal of Thoracic andelevated PAP is a good marker for
increased morbidity and mortality,
the potential underlying reason for
worse outcomes in these patients is
right heart dysfunction.
For better independent quantifica-
tion of right heart function, we have
begun implementing cardiac magnetic
resonance imaging (cMRI) on a
routine basis for patients deemed to
be at increased risk for right heart
dysfunction arising from elevated
PAP. Use of cMRI allows accurate
interpretation of right ventricular
ejection fraction as well as chamber
volumes or right ventricular end-
diastolic and end-systolic volumes,
which serve as the criterion standard
for establishment of right heart func-
tion in patients with elevated PAP.3
We perform cMRI selectively during
our preoperative workup in patients
with suspected elevated PAP and in
those deemed to be at risk for possible
right heart dysfunction, such as pa-
tients with valvular heart disease and
those with ischemic cardiomy-
opathy.4-6 Patients who are not found
to have any associated right heart
dysfunction are then reevaluated
to establish whether there are
interventions available for medical
optimization, because increased PAP
is often due to other reversible
cardiac causes or noncardiogenic
causes in this subset (sleep apnea,
volume overload, interstitial lung
disease, etc).4 Those who demonstrate
severe right heart dysfunction are also
reevaluated for medical optimization,
as well as for appropriateness of
surgical intervention, especially in
patients with apparent advanced
biventricular disease. Within our
population, this method has allowed
us to improve preoperative risk
stratification and our ability to
select appropriate surgical candidates,
improving our outcomes.5,6
We believe that cMRI should be
used in patients with elevated PAP
(mean PAP >35 mm Hg) to help
define right ventricular function and
better select patients for cardiacCardiovascular Surgery c May 2014surgical procedures. Consideration
should be also given to adding right
heart function to existing risk models
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We appreciate the comments by Tra-
chiotis and colleagues on the impor-
tance of right ventricular (RV)
function in perioperative morbidity
and mortality. We agree that a compre-
hensive assessment of RV function
Letters to the Editorincludes imaging data, such as cardio-
vascular magnetic resonance imaging
(MRI) or echocardiography, and com-
plete hemodynamic assessment and
laboratory data. Cardiovascular MRI
generally provides superior RV func-
tional assessment compared with echo-
cardiography. Unfortunately, not all
patients being evaluated for cardiac
surgery are candidates for cardiovascu-
lar MRI because of hemodynamic
instability or the presence of incompat-
ible devices, such as pacemakers or de-
fibrillators, intra-aortic balloon pumps,
and left ventricular assist devices.
Echocardiography, either transthoracic
or transesophageal, can be performed
at the bedside or in the operating
room, and therefore has the advantage
of providing immediate feedback on
the impact of various interventions,
such as fluid administration, adjust-
ment of ventilator parameters, pressor
and inotrope adjustment, and weaning
from cardiopulmonary bypass.
A thorough hemodynamic evalua-
tion is required to interpret the signif-
icance of pulmonary artery pressures.
As RV dysfunction progresses to
outright RV failure, pulmonary pres-
sures and cardiac output decrease,
and right atrial pressure increases.
This concept has been used widely to
predict the risk of RV failure after
left ventricular assist device place-
ment with the RV stroke work index
([pulmonary artery mean – radial ar-
tery mean] $ confidence interval/haz-
ard ratio).1 A simpler determination
of the ratio of right atrial pressure to
pulmonary capillary wedge pressure
is insightful, with values greater than
0.63 indicating higher risk for RV
failure.2
Finally, laboratory evaluation of he-
patic and renal function provides
another means of assessing RV func-
tion. Elevated aspartate aminotrans-
ferase, bilirubin, and blood urea
nitrogen are predictive of RV failure
after left ventricular assist device
placement.2,3 Likewise, the Model
for End-Stage Liver Disease, consist-
ing of total bilirubin, internationalThe Journalnormalized ratio, and creatinine, pre-
dicts mortality for tricuspid valve
surgery.4
The final major point of our publica-
tion is that pulmonary hypertension
in the setting of isolated coronary ar-
tery bypass grafting carries a higher
risk compared with valvular heart dis-
ease, likely because pulmonary pres-
sures rapidly improve with correction
of valve lesions but not with revas-
cularization.5
Jamie L. W. Kennedy, MDa
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I have read with great interest the
article by Fino and colleagues.1 Their
conclusions are very interesting.of Thoracic and Cardiovascular SurgerHowever, it would seem that the
success rate achieved with the
technique described originally by
Bolling and colleagues2 is unaccep-
table and the complication rate is
unacceptably high. Restrictive mitral
annuloplasty inserting a small ring,
often 26 mm or 28 mm, is based on
the principle of anterior advancement
of the posterior mitral annulus. So,
the tethered posterior leaflet (PL)
meets the anterior leaflet in a more
anterior displaced closure line.
Consequently, the effective mitral
valve area is reduced. Complete
prosthetic annuloplasty rings to treat
chronic ischemic mitral regurgitation
are an absolute must because there
is an anteroposterior annular enlarge-
ment3 in addition to the asymmetric
PL tethering.4 It is therefore clear
that, in restrictive mitral annulo-
plasty, the higher the PL angle, the
greater the need for mitral valve
closure line anterior displacement,
and more likely the possibility of
over reduction of the mitral valve
area. We have addressed this issue
in the study by Magne and col-
leagues.5 Restrictive mitral annulo-
plasty in chronic ischemic mitral
regurgitation is most likely to fail
in patients with a PL angle
greater than 45 degrees by
echocardiographic study. The best
predictor of postoperative persistence
of mitral regurgitation was a PL
angle greater than 45 degrees. Since
2011, we have selected exclusively
patients with a PL angle less than
45 degrees for restrictive mitral valve
annuloplasty in chronic ischemic
mitral regurgitation. This approach
has drastically reduced the need to
use very small rings. We had no
need to use 26-mm rings. Usually,
28-mm or 30-mm complete rings
achieve good mitral coaptation while
solving the problem of over reduc-
tion. This fact may be due to a
decreased need for anterior displace-
ment of the mitral valve closure line
when the PL angle is less than 45
degrees.y c Volume 147, Number 5 1717
